###begin article-title 0
###xml 51 57 51 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL12B </italic>
A replication study of the association between the IL12B promoter allele CTCTAA and susceptibility to cerebral malaria in Thai population
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 197 203 197 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL12B </italic>
###xml 212 218 212 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL12B </italic>
Interleukin-12 (IL-12), a heterodimeric cytokine composed of p35 and p40 subunits, has been thought to play an important role in the pathogenesis of malaria. The IL-12p40 subunit is encoded by the IL12B gene. An IL12B promoter allele, CTCTAA, at rs17860508 has been reported to be associated with susceptibility to cerebral malaria in African populations. However, this association has not so far been replicated in non-African populations.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 136 158 136 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium falciparum </italic>
###xml 122 130 <span type="species:ncbi:9606">patients</span>
###xml 136 157 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 209 217 <span type="species:ncbi:9606">patients</span>
To examine whether the CTCTAA allele is associated with susceptibility to cerebral malaria in Asian populations, 303 Thai patients with Plasmodium falciparum malaria (109 cerebral malaria and 194 mild malaria patients) were genotyped for rs17860508 by PCR-direct sequencing.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 144 145 144 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
The CTCTAA allele showed a significant association with susceptibility to cerebral malaria in the Thai population (allelic OR = 1.37; one sided P-value = 0.030).
###end p 6
###begin title 7
Conclusions
###end title 7
###begin p 8
The existence of a significant association between the CTCTAA allele and susceptibility to cerebral malaria was confirmed in Southeast Asian population, which was previously reported in African populations.
###end p 8
###begin title 9
Background
###end title 9
###begin p 10
###xml 35 57 35 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium falciparum </italic>
###xml 112 126 112 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum </italic>
###xml 513 514 513 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 515 516 515 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 596 597 596 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 598 599 598 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 675 676 675 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 35 56 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 112 125 <span type="species:ncbi:5833">P. falciparum</span>
###xml 368 376 <span type="species:ncbi:9606">patients</span>
###xml 442 450 <span type="species:ncbi:9606">patients</span>
###xml 723 731 <span type="species:ncbi:9606">patients</span>
###xml 758 763 <span type="species:ncbi:9606">human</span>
Cerebral malaria, a severe form of Plasmodium falciparum malaria, causes the vast majority of deaths related to P. falciparum infection. Although the pathophysiology of severe malaria (including cerebral malaria) is not fully understood, significant differences in serum or plasma concentrations of various cytokines have been observed between severe and mild malaria patients. The levels of interleukin-12 (IL-12) are significantly lower in patients with severe malaria in comparison to those with mild malaria [1,2]. In animal models of malaria, IL-12 has been shown to have a protective role [3-5], although pathogenic effects of IL-12 in malaria have also been reported [5]. Considering the fact that only some malaria patients develop cerebral malaria, human genetic polymorphisms may play an important role in determining the severity of the disease. In this context, genes encoding IL-12 are attractive candidates for determining the susceptibility to cerebral malaria.
###end p 10
###begin p 11
###xml 183 189 183 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL12B </italic>
###xml 199 205 199 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL12B </italic>
###xml 453 454 453 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 455 456 455 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 586 587 586 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 730 732 730 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 892 898 892 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL12B </italic>
###xml 554 562 <span type="species:ncbi:9606">children</span>
Interleukin-12 (IL-12) is a heterodimeric cytokine formed by a 35-kDa light chain (p35 or IL-12a) and a 40-kDa heavy chain (p40 or IL-12b). The IL-12p40 heavy chain is encoded by the IL12B gene. The IL12B has a functional polymorphism, CTCTAA/GC (rs17860508), with a 4 bp difference between the two alleles in the promoter region. The CTCTAA/GC polymorphism has been shown to affect the gene expression and the production of cytokines and nitric oxide [6-9]. The homozygotes of CTCTAA were reported to be associated with increased mortality in Tanzanian children with cerebral malaria [9]. Recently, the strong association of CTCTAA with the risk of cerebral malaria was also observed in family-based association studies in Mali [10]. However, this association has not yet been examined in non-African populations, such as Southeast Asians. The purpose of this study is to assess whether the IL12B promoter allele, CTCTAA, is associated with susceptibility to cerebral malaria in Thais.
###end p 11
###begin title 12
Methods
###end title 12
###begin title 13
Subjects
###end title 13
###begin p 14
###xml 35 49 35 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum </italic>
###xml 312 326 312 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum </italic>
###xml 406 419 406 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 674 687 674 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 21 29 <span type="species:ncbi:9606">patients</span>
###xml 35 48 <span type="species:ncbi:5833">P. falciparum</span>
###xml 100 108 <span type="species:ncbi:9606">patients</span>
###xml 172 180 <span type="species:ncbi:9606">patients</span>
###xml 312 325 <span type="species:ncbi:5833">P. falciparum</span>
###xml 347 355 <span type="species:ncbi:9606">patients</span>
###xml 406 419 <span type="species:ncbi:5833">P. falciparum</span>
###xml 674 687 <span type="species:ncbi:5833">P. falciparum</span>
###xml 1148 1156 <span type="species:ncbi:9606">patients</span>
###xml 1196 1204 <span type="species:ncbi:9606">patients</span>
###xml 1427 1432 <span type="species:ncbi:9606">Human</span>
###xml 1505 1513 <span type="species:ncbi:9606">patients</span>
A total of 303 adult patients with P. falciparum malaria (109 cerebral malaria and 194 mild malaria patients) living in northwest Thailand were analysed in this study. All patients underwent treatment at the Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University. Malarial infection by P. falciparum was confirmed in all patients by a positive blood smear for the asexual form of P. falciparum. Clinical manifestations of malaria were classified according to the definitions and associated criteria by the World Health Organization. Cerebral malaria was defined as unrousable coma, a positive result in tests for the presence of an asexual form of P. falciparum, and exclusion of other causes of coma. Mild malaria was defined as having a positive blood smear and fever without other causes of infection and no signs indicating severe malaria such as high parasitaemia (> 100,000 parasites/ml), hypoglycemia (glucose level < 22 nmol/L), severe anaemia (haematocrit < 20% or hemoglobin level < 7.0 g/dl) or increased serum level of creatinine (> 3.0 mg/dl). All individuals were 13 years old or older, and the mean ages of patients with mild malaria and cerebral malaria patients were 25.5 and 28.6 respectively. This study was approved by the institutional review board of the Faculty of Tropical Medicine, Mahidol University, and the Research Ethics Committee of the Graduate School of Comprehensive Human Sciences, University of Tsukuba. Informed consent was obtained from all patients.
###end p 14
###begin title 15
Genotyping
###end title 15
###begin p 16
###xml 115 121 115 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL12B </italic>
Genomic DNA was extracted from peripheral blood leukocytes using a QIAamp Blood Kit (Qiagen, Hilden, Germany). The IL12B promoter polymorphism, rs17860508, was genotyped by PCR-direct sequencing with an ABI PRISMTM 3100 Genetic Analyzer (Perkin-Elmer Applied Biosystems). PCR was performed using a primer set: a 5' primer IL12B-proF: 5'-GGATCAGGGTCTGGATTGTG-3' and a 3' primer IL12B-proR: 5'-GGCTGATGCTTGGAGATTGT-3'. The amplification condition consisted of an initial denaturation at 96degreesC for 10 min, followed by 35 cycles of denaturation at 96degreesC for 30 sec, annealing at 60degreesC for 30 sec, and extension at 72degreesC for 1 min using a thermal cycler (GeneAmp PCR system 9700; Perkin-Elmer Applied Biosystems).
###end p 16
###begin title 17
Statistical analysis
###end title 17
###begin p 18
###xml 195 196 195 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 531 532 531 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 63 71 <span type="species:ncbi:9606">patients</span>
The differences in genotype and allele frequencies between the patients with cerebral and mild malaria were examined by the Cochran-Armitage test for trend and chi-square test, respectively. The P-values for association were calculated by a one-sided test to avoid a false negative because the CTCTAA allele had been previously reported to be associated with both susceptibility to and mortality from cerebral malaria. The deviation from Hardy-Weinberg equilibrium (HWE) for each malaria group was assessed by a chi-square test. A P-value of less than 0.05 was regarded as statistically significant in this study.
###end p 18
###begin title 19
Results and Discussion
###end title 19
###begin p 20
###xml 81 82 81 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 156 157 156 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 370 371 370 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 528 529 528 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 658 660 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 52 60 <span type="species:ncbi:9606">patients</span>
###xml 853 861 <span type="species:ncbi:9606">patients</span>
The genotype of rs17860508 was analysed in 303 Thai patients with malaria (Table 1). The genotype frequency did not deviate from HWE in each malaria group (P-value > 0.05). Consistent with observations in African populations, the CTCTAA allele showed a significant association with susceptibility to cerebral malaria in the Thai population (allelic OR = 1.37; one sided P-value = 0.030). The Cochran-Armitage trend test for the genotype frequency also established the association between the CTCTAA allele and cerebral malaria (P-value = 0.038). Although a previous study demonstrated that the CTCTAA/GC heterozygotes increased the risk of cerebral malaria [10], such a tendency was not observed in the present study. In Thais, the risk of cerebral malaria seems to correlate with the number of copies of the CTCTAA allele (i.e., 0, 1, or 2) in malaria patients. This may be the ethnic difference between African and Asian.
###end p 20
###begin p 21
###xml 39 45 39 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL12B </italic>
###xml 83 91 <span type="species:ncbi:9606">patients</span>
Genotype and allele frequencies of the IL12B promoter polymorphism in Thai malaria patients.
###end p 21
###begin p 22
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 11 12 11 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
aOne-sided P-value was calculated based on the result from the Cochran-Armitage test for trend.
###end p 22
###begin p 23
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 11 12 11 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
bOne-sided P-value was calculated based on the result from chi-square test.
###end p 23
###begin p 24
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 107 115 <span type="species:ncbi:9606">children</span>
###xml 608 616 <span type="species:ncbi:9606">children</span>
The significant association of the CTCTAA allele with susceptibility to cerebral malaria was found both in children living in Mali [10] and in Thai adults (this study). In areas of low endemicity, where the immunity is low, severe infection occurs in all age groups including adults as in the studied population. Since the endemicity differs between Africa and Southeast Asia, it should not readily be concluded that the present association of the CTCTAA allele with susceptibility to cerebral malaria is independent of age. To evaluate this, further association studies are required to be conducted in Thai children.
###end p 24
###begin p 25
###xml 37 43 37 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL12B </italic>
The present results suggest that the IL12B promoter polymorphism at rs17860508 plays an important role in determining the onset of cerebral malaria, although the role of IL-12 in malaria infection remains to be studied.
###end p 25
###begin title 26
Conclusions
###end title 26
###begin p 27
###xml 33 39 33 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL12B </italic>
A significant association of the IL12B promoter CTCTAA allele with cerebral malaria was replicated in a Thai population.
###end p 27
###begin title 28
Competing interests
###end title 28
###begin p 29
The authors declare that they have no competing interests.
###end p 29
###begin title 30
Authors' contributions
###end title 30
###begin p 31
NI performed the genotyping, helped conduct statistical analyses, and wrote the manuscript. KT helped genotype the samples. JP and HH collected blood samples and extracted DNA. JP and JO participated in the design and coordination of the study. NT was involved in the interpretation of the data and preparation of the manuscript. JO performed statistical analyses and helped write the manuscript. All authors read and approved the final manuscript.
###end p 31
###begin title 32
Acknowledgements
###end title 32
###begin p 33
###xml 32 40 <span type="species:ncbi:9606">patients</span>
The authors sincerely thank all patients who kindly participated in this study, and also thank two anonymous reviewers for their valuable comments and suggestions regarding this manuscript. This study was supported in part by research funds KAKENHI Grant-in-Aid for Scientific Research on Priority Areas "Comprehensive Genomics" and "Applied Genomics" from the Ministry of Education, Culture, Sports, Science and Technology of Japan.
###end p 33
###begin article-title 34
###xml 38 59 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Low interleukin-12 activity in severe Plasmodium falciparum malaria
###end article-title 34
###begin article-title 35
Reduced interleukin-12 and transforming growth factor-beta1 in severe childhood malaria: relationship of cytokine balance with disease severity
###end article-title 35
###begin article-title 36
Interleukin-12 and malaria
###end article-title 36
###begin article-title 37
Therapy with a combination of low doses of interleukin 12 and chloroquine completely cures blood-stage malaria, prevents severe anemia, and induces immunity to reinfection
###end article-title 37
###begin article-title 38
Modulation of host responses to blood-stage malaria by interleukin-12: from therapy to adjuvant activity
###end article-title 38
###begin article-title 39
###xml 92 100 <span type="species:ncbi:9606">children</span>
Association of IL12B promoter polymorphism with severity of atopic and non-atopic asthma in children
###end article-title 39
###begin article-title 40
Deficient IL-12p70 secretion by dendritic cells based on IL12B promoter genotype
###end article-title 40
###begin article-title 41
IL10 and IL12B polymorphisms each influence IL-12p70 secretion by dendritic cells in response to LPS
###end article-title 41
###begin article-title 42
A promoter polymorphism in the gene encoding interleukin-12 p40 (IL12B) is associated with mortality from cerebral malaria and with reduced nitric oxide production
###end article-title 42
###begin article-title 43
A functional promoter variant in IL12B predisposes to cerebral malaria
###end article-title 43

